Danaher Management
Management Kriterienprüfungen 3/4
Danaher CEO ist Rainer Blair , ernannt in Sep 2020, hat eine Amtszeit von 4.17 Jahren. Die jährliche Gesamtvergütung beträgt $20.90M , bestehend aus 6.2% Gehalt und 93.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.014% der Aktien des Unternehmens, im Wert von $24.51M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.8 Jahre bzw. 14.5 Jahre.
Wichtige Informationen
Rainer Blair
Geschäftsführender
US$20.9m
Gesamtvergütung
Prozentsatz des Geschäftsführergehalts | 6.2% |
Amtszeit als Geschäftsführer | 4.2yrs |
Eigentum des Geschäftsführers | 0.01% |
Durchschnittliche Amtszeit des Managements | 5.8yrs |
Durchschnittliche Amtszeit der Vorstandsmitglieder | 14.5yrs |
Jüngste Management Updates
Recent updates
Understanding Danaher's Cautiousness
Oct 25Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year
May 01Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price
Sep 30Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 28Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?
Jun 15Danaher: A Great Chance To Buy This Long-Term Compounder
May 23With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case
Apr 26Analyse der Geschäftsführervergütung
Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
---|---|---|---|
Sep 27 2024 | n/a | n/a | US$4b |
Jun 28 2024 | n/a | n/a | US$4b |
Mar 29 2024 | n/a | n/a | US$4b |
Dec 31 2023 | US$21m | US$1m | US$4b |
Sep 29 2023 | n/a | n/a | US$4b |
Jun 30 2023 | n/a | n/a | US$5b |
Mar 31 2023 | n/a | n/a | US$6b |
Dec 31 2022 | US$20m | US$1m | US$6b |
Sep 30 2022 | n/a | n/a | US$7b |
Jul 01 2022 | n/a | n/a | US$6b |
Apr 01 2022 | n/a | n/a | US$6b |
Dec 31 2021 | US$17m | US$1m | US$5b |
Oct 01 2021 | n/a | n/a | US$6b |
Jul 02 2021 | n/a | n/a | US$5b |
Apr 02 2021 | n/a | n/a | US$5b |
Dec 31 2020 | US$10m | US$949k | US$4b |
Oct 02 2020 | n/a | n/a | US$3b |
Jul 03 2020 | n/a | n/a | US$3b |
Apr 03 2020 | n/a | n/a | US$3b |
Dec 31 2019 | US$7m | US$840k | US$2b |
Sep 27 2019 | n/a | n/a | US$2b |
Jun 28 2019 | n/a | n/a | US$2b |
Mar 29 2019 | n/a | n/a | US$2b |
Dec 31 2018 | US$5m | US$700k | US$2b |
Sep 28 2018 | n/a | n/a | US$3b |
Jun 29 2018 | n/a | n/a | US$3b |
Mar 30 2018 | n/a | n/a | US$3b |
Dec 31 2017 | US$4m | US$625k | US$2b |
Vergütung im Vergleich zum Markt: RainerDie Gesamtvergütung ($USD20.90M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.86M).
Entschädigung vs. Einkommen: RainerDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Rainer Blair (60 yo)
4.2yrs
Amtszeit
US$20,903,282
Vergütung
Mr. Rainer M. Blair serves as Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September 1, 2020. Mr. Blair served as...
Führungsteam
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
Co-Founder & Chairman | 41.8yrs | keine Daten | 6.02% $ 10.9b | |
President | 4.2yrs | US$20.90m | 0.014% $ 24.5m | |
Co-Founder & Director | 41.8yrs | keine Daten | 4.86% $ 8.8b | |
CFO & Executive VP | 5.8yrs | US$7.50m | 0.0053% $ 9.6m | |
Senior VP & Chief Science Officer | 3.9yrs | US$7.20m | 0.00037% $ 668.3k | |
Senior Vice President of Human Resources | 2.6yrs | US$5.25m | 0.00015% $ 270.9k | |
VP & Chief Accounting Officer | 2.8yrs | keine Daten | 0.00081% $ 1.5m | |
Vice President of Investor Relations | no data | keine Daten | keine Daten | |
Senior VP | 8.8yrs | US$3.56m | 0.0028% $ 5.1m | |
Senior Vice President of Corporate Development | 14.8yrs | keine Daten | 0.0033% $ 5.9m | |
Senior Vice President of Strategic Development | 10.5yrs | keine Daten | 0.0067% $ 12.0m | |
Executive VP of Biotechnology Group & CEO of Cytiva | less than a year | keine Daten | 0.0020% $ 3.6m |
5.8yrs
Durchschnittliche Betriebszugehörigkeit
57yo
Durchschnittliches Alter
Erfahrenes Management: DHRDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.8 ).
Vorstandsmitglieder
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
Co-Founder & Chairman | 41.8yrs | keine Daten | 6.02% $ 10.9b | |
President | 4.2yrs | US$20.90m | 0.014% $ 24.5m | |
Co-Founder & Director | 41.8yrs | keine Daten | 4.86% $ 8.8b | |
Independent Director | 25.8yrs | US$338.13k | 0.011% $ 20.4m | |
Independent Director | 21.3yrs | US$351.13k | 0.0054% $ 9.8m | |
Independent Director | 15.8yrs | US$338.13k | 0.0024% $ 4.3m | |
Independent Director | 7.8yrs | US$318.13k | 0% $ 0 | |
Member of Scientific Advisory Board | 3.6yrs | keine Daten | keine Daten | |
Lead Independent Director | 18.9yrs | US$382.13k | 0.0057% $ 10.3m | |
Independent Director | 13.2yrs | US$318.13k | 0% $ 0 | |
Independent Director | 5yrs | US$318.13k | 0% $ 0 | |
Director | 5yrs | US$318.13k | 0% $ 0 |
14.5yrs
Durchschnittliche Betriebszugehörigkeit
64yo
Durchschnittliches Alter
Erfahrener Vorstand: DHRDie Vorstandsmitglieder sind sehr erfahren ( 14.5 ).